We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0QQJ market cap is 1.91M. The company's latest EPS is CHF -14.5525 and P/E is -0.06.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 11.6M | 7.54M | 9.88M | 15.54M | 9.44M |
| Operating Income | -20.13M | -24.91M | -42.03M | -40.39M | -92.24M |
| Net Income | -21.64M | -29.87M | -41.27M | -43.37M | -105.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 192.08M | 166.89M | 156.17M | 131.01M | 9.83M |
| Total Liabilities | 19.52M | 21.8M | 24.4M | 24.77M | 4.28M |
| Total Equity | 172.56M | 145.09M | 131.77M | 106.24M | 5.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -14.16M | -23.36M | -29.79M | -18.88M | -9.26M |
| Investing | -5.33M | -5.6M | -4.64M | -1.76M | 15.95M |
| Financing | -920k | 8.86M | 25.72M | 14.77M | -5.97M |
| Market Cap | 1.91M |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 0.69 |
| Price to Cash Ratio | 1.11 |
| Price to Book Ratio | 1.17 |
| Dividend Yield | - |
| Shares Outstanding | 7.23M |
| Average Volume (1 week) | 1 |
| Average Volume (1 Month) | 47 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.264 |
| 52 Week Low | 0.264 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Evolva Holding Sa |
| Address |
duggingerstra��e 23 reinach 4153 |
| Website | https://www.evolva.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
